Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Hartmann

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Organic & Biomolecular Chemistry|September 5, 2015
Steering the azido-tetrazole equilibrium of 4-azidopyrimidines via substituent variation - implications for drug design and azide-alkyne cycloadditionsA Thomann, J Zapp, M Hutter, et al.
Planta Medica|April 1, 1997
Inhibition of 5 alpha-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium speciesB Ducrey, A Marston, S Göhring, et al.
Archiv Der Pharmazie|January 9, 1999
Spectrofluorimetric quantification of malondialdehyde for evaluation of cyclooxygenase-1/thromboxane synthase inhibitionG Dannhardt, L Flemmer, R W Hartmann, et al.
Die Pharmazie|August 8, 2006
[Derivatives of exemestane--synthesis and evaluation of aromatase inhibition]K Görlitzer, Ch Bonnekessel, P G Jones, et al.
Anti-Cancer Drug Design|January 5, 2002
Synthesis, evaluation and QSAR studies of highly potent aromatase inhibitors of the piperidinedione typeE Baston, C D Klein, W Grimminger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutaneW Schwarz, R W Hartmann, J Engel, et al.
Archiv Der Pharmazie|February 1, 1990
Cytotoxic ester derivatives of the mammary tumor inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutaneW Schwarz, R W Hartmann, J Engel, et al.
Biological Psychiatry|January 1, 1971
Brief conceptual (nonreal) events during eye movementD W Kennard, R W Hartmann, D P Kraft, et al.
Archiv Der Pharmazie|July 1, 1995
4,5-Dihydro-3-(2-pyrazinyl)naphtho[1,2-c]pyrazole: a potent and selective inhibitor of steroid-17 alpha-hydroxylase-C17,20-lyase (P450 17)R W Hartmann, G A Wächter, T Sergejew, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1982
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compoundG Kranzfelder, R W Hartmann, E von Angerer, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Organic & Biomolecular Chemistry|September 5, 2015
Steering the azido-tetrazole equilibrium of 4-azidopyrimidines via substituent variation - implications for drug design and azide-alkyne cycloadditionsA Thomann, J Zapp, M Hutter, et al.
Planta Medica|April 1, 1997
Inhibition of 5 alpha-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium speciesB Ducrey, A Marston, S Göhring, et al.
Archiv Der Pharmazie|January 9, 1999
Spectrofluorimetric quantification of malondialdehyde for evaluation of cyclooxygenase-1/thromboxane synthase inhibitionG Dannhardt, L Flemmer, R W Hartmann, et al.
Die Pharmazie|August 8, 2006
[Derivatives of exemestane--synthesis and evaluation of aromatase inhibition]K Görlitzer, Ch Bonnekessel, P G Jones, et al.
Anti-Cancer Drug Design|January 5, 2002
Synthesis, evaluation and QSAR studies of highly potent aromatase inhibitors of the piperidinedione typeE Baston, C D Klein, W Grimminger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutaneW Schwarz, R W Hartmann, J Engel, et al.
Archiv Der Pharmazie|February 1, 1990
Cytotoxic ester derivatives of the mammary tumor inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutaneW Schwarz, R W Hartmann, J Engel, et al.
Biological Psychiatry|January 1, 1971
Brief conceptual (nonreal) events during eye movementD W Kennard, R W Hartmann, D P Kraft, et al.
Archiv Der Pharmazie|July 1, 1995
4,5-Dihydro-3-(2-pyrazinyl)naphtho[1,2-c]pyrazole: a potent and selective inhibitor of steroid-17 alpha-hydroxylase-C17,20-lyase (P450 17)R W Hartmann, G A Wächter, T Sergejew, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1982
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compoundG Kranzfelder, R W Hartmann, E von Angerer, et al.
Pageof 9